Authors:
Velosa, JA
Larson, TS
Gloor, JM
Stegall, MD
Citation: Ja. Velosa et al., Cyclosporine elimination in the presence of TOR inhibitors: Effects on renal function, acute rejection, and safety, AM J KIDNEY, 38(4), 2001, pp. S3-S10
Authors:
Dean, PG
Cohen, AJ
Dalla Valle, H
Grande, JP
Diamond, LE
Byrne, GW
Logan, JS
McGregor, CGA
Stegall, MD
Citation: Pg. Dean et al., The effect of anti-alpha Gal antibody removal with immunoabsorption and splenectomy on CD46 transgenic kidney xenograft survival, TRANSPLAN P, 33(1-2), 2001, pp. 721-722
Citation: Md. Stegall et al., Sharing 0-antigen mismatched cadaveric kidneys does not decrease the graftsurvival of payback kidneys, TRANSPLAN P, 33(1-2), 2001, pp. 920-921
Authors:
Stegall, MD
Kim, DY
Prieto, M
Cohen, AJ
Griffin, MD
Schwab, TR
Nyberg, SL
Velosa, JA
Gloor, JM
Innocenti, F
Bohorquez, H
Dean, PG
Carpenter, HA
Leontovich, ON
Sterioff, S
Larson, TS
Citation: Md. Stegall et al., Thymoglobulin induction decreases rejection in solitary pancreas transplantation, TRANSPLANT, 72(10), 2001, pp. 1671-1675
Authors:
Stegall, MD
Elices, M
Shepard, G
Gup, C
Ninova, D
Ferguson, D
Gill, RG
Citation: Md. Stegall et al., The 2C T-cell transgenic mouse: An in vivo model of allospecific cytotoxicT-cell activation and homing, TRANSPLAN P, 31(1-2), 1999, pp. 779-779
Authors:
Stegall, MD
Elices, M
Pietra, W
Shepard, G
Gup, C
Gill, RG
Citation: Md. Stegall et al., Different roles for alpha 4-lntegrin/VCAM-1 and alpha 4/fibronectin interactions in allograft rejection, TRANSPLAN P, 31(1-2), 1999, pp. 786-786